未登录

J

Julie Bolcaen

psi center for life sciences

H指数:14

被引数:542

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tolerability of [161Tb]Tb-SibuDAB in comparison to other PSMA-targeting radioligands in the preclinical setting

[161Tb]Tb-SibuDAB与其他PSMA靶向放射性配体的耐受性比较：在预临床研究中的评估

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2026-08-130

OA

Absorbed doses to single cells from radionuclides Tb-161; Pd-103; Pd-109; and Er-165 in different cellular compartments and neighbour cells

来自放射性核素Tb-161、Pd-103、Pd-109和Er-165对不同细胞器及邻近细胞的单细胞吸收剂量

Physics in Medicine & Biology

IF0

2025-12-230

OAAI

Auger radioisotopes as the next frontier in therapeutic Nuclear Medicine – A micro-dosimetry study comparing membrane and nuclear doses between different Auger emitting radionuclides

俄歇放射核素作为治疗核医学的下一个前沿——一项关于不同俄歇发射放射性核素间膜剂量与核剂量比较的微剂量学研究

Nuclear Medicine and Biology

IF3

2025-11-100

PRE

Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy

编组俄歇电子放射性药物治疗的潜力

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2023-08-1725

OA

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy

PHARMACEUTICALS

IF4.8

2023-02-0111

OAAI

Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer

PHARMACEUTICALS

IF4.8

2023-01-313

OAAI

DNA damage response of haematopoietic stem and progenitor cells to high-LET neutron irradiation

SCIENTIFIC REPORTS

IF3.9

2021-10-216

OAAI

MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy

MDM2/X抑制剂作为胶质母细胞瘤靶向治疗的放射增敏剂

FRONTIERS IN ONCOLOGY

IF3.3

2021-07-0829

OAAI

Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma

PHARMACEUTICALS

IF4.8

2021-06-2914

OAAI

A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma

IF13.3

2021-01-0131

OAAI

Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model

RADIATION ONCOLOGY

IF3.2

2019-05-307

OAAI

Magnetic resonance based small animal radiotherapy in neuro-oncology

RADIOTHERAPY AND ONCOLOGY

IF5.3

2019-04-010

OAAI

New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma

SCIENTIFIC REPORTS

IF3.9

2019-02-2720

OAAI

The Path Toward PET-Guided Radiation Therapy for Glioblastoma in Laboratory Animals: A Mini Review

FRONTIERS IN MEDICINE

IF3

2019-01-298

OAAI

In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats

体内dce-mri用于区分大鼠胶质母细胞瘤和放射性坏死

MOLECULAR IMAGING AND BIOLOGY

IF2.5

2017-03-1615

PREAI

18F-fluoromethylcholine (FCho), 18F-fluoroethyltyrosine (FET), and 18F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: A PET study

NUCLEAR MEDICINE AND BIOLOGY

IF3

2015-01-0130

PREAI

MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP)

JOURNAL OF NEURO-ONCOLOGY

IF3.1

2014-07-2935

PREAI